HK Stock Price Fluctuated | VOBILE GROUP (03738) rose nearly 5% with a year-on-year increase of approximately 31% in total revenue for Q3. The company is expected to benefit from the overall development of the digital content industry.
Connect the global capital markets.
VOBILE GROUP (03738) rose by nearly 5% in mid-day trading and as of the time of writing, it increased by 4.53% to HKD 2.54, with a turnover of HKD 17.2291 million.
On the news front, VOBILE GROUP released its operating data for the third quarter of 2023. For the three months ended September 30, 2023, the company's total revenue increased by approximately 31% compared to the same period last year. Calculated in RMB, the revenue from its mainland China business increased by 33% compared to the same period last year. Among them, the monthly recurring revenue increased by approximately 37% compared to the same period last year. The company's global business revenue showed steady growth.
Soochow previously pointed out that as one of the leading enterprises in the field of digital content asset protection and trading, Fubo has a sound infrastructure for data element management and has experience in monetizing short videos on global social media platforms. With its cutting-edge layout in fingerprint technology and watermark technology, it is expected to benefit from the overall development of the digital content industry.
Related Articles

US Stock Market Move | Ticketplus Ltd (TP.US) debuted on the U.S. stock market, dropping over 15% after opening.

US Stock Market Move | Latigo Biotherapeutics (LTGO.US) debuts on the U.S. stock market, with its stock price rising over 14% after opening.

In July, the U.S. non-farm payroll unexpectedly turned negative, dealing a heavy blow to the dollar. The market has lowered its expectations for a rate hike in September, and the Federal Reserve may continue to hold its position.
US Stock Market Move | Ticketplus Ltd (TP.US) debuted on the U.S. stock market, dropping over 15% after opening.

US Stock Market Move | Latigo Biotherapeutics (LTGO.US) debuts on the U.S. stock market, with its stock price rising over 14% after opening.

In July, the U.S. non-farm payroll unexpectedly turned negative, dealing a heavy blow to the dollar. The market has lowered its expectations for a rate hike in September, and the Federal Reserve may continue to hold its position.

RECOMMEND





